相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA
Pasquale Paolisso et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence
Sonia Khemais-Benkhiat et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients
Nunzia D'Onofrio et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Comparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis
Salomeh Keyhani et al.
JAMA NEUROLOGY (2020)
SGLT2i: beyond the glucose-lowering effect
Lihua Ni et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors
Milton Packer
CIRCULATION-HEART FAILURE (2020)
Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
Takayoshi Suga et al.
WORLD JOURNAL OF HEPATOLOGY (2020)
Minimizing Hyperglycemia-Induced Vascular Endothelial Dysfunction by Inhibiting Endothelial Sodium-Glucose Cotransporter 2 and Attenuating Oxidative Stress: Implications for Treating Individuals With Type 2 Diabetes
Vivek Krishna Pulakazhi Venu et al.
CANADIAN JOURNAL OF DIABETES (2019)
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
Binayak Sinha et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation
Ghazaleh Behnammanesh et al.
FRONTIERS IN PHARMACOLOGY (2019)
The dating of thrombus organization in cases of pulmonary embolism: an autopsy study
Gelsomina Mansueto et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Thomas R. Einarson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
Hiroyuki Umino et al.
SCIENTIFIC REPORTS (2018)
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet
Ji Hye Han et al.
DIABETOLOGIA (2017)
Histological fibrosis may predict the failure of core decompression in the treatment of osteonecrosis of the femoral head
Francesco Sadile et al.
INTERNATIONAL JOURNAL OF SURGERY (2017)
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE-/- Mice
Weiling Leng et al.
MEDIATORS OF INFLAMMATION (2016)
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
Linda A. Gallo et al.
DIABETES & VASCULAR DISEASE RESEARCH (2015)
Sirtuin 6 Expression and Inflammatory Activity in Diabetic Atherosclerotic Plaques: Effects of Incretin Treatment
Maria Luisa Balestrieri et al.
DIABETES (2015)
Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice
Michishige Terasaki et al.
PLOS ONE (2015)
Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox
Giampaolo Niccoli et al.
EUROPEAN HEART JOURNAL (2013)
Sirtuin 6: a review of biological effects and potential therapeutic properties
Jade M. Beauharnois et al.
MOLECULAR BIOSYSTEMS (2013)
Endothelial progenitor cells in atherosclerosis
Fuyong Du et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun
Nagalingam R. Sundaresan et al.
NATURE MEDICINE (2012)
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque - Effects of rosiglitazone treatment
Raffaele Marfella et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke
LG Spagnoli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
分享论文
